![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The Therapeutic Potential of GLP-1](https://ars.els-cdn.com/content/image/1-s2.0-S0001731023008505-fx1.jpg)
glp-1 and hs
Shipping Estimate
glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The Therapeutic Potential of GLP-1
EUR27.74
EUR67.74
Pay in 4 interest-free payments of $6.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The Therapeutic Potential of GLP-1](https://www.mdpi.com/jcm/jcm-13-06292/article_deploy/html/images/jcm-13-06292-g002.png)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The Therapeutic Potential of GLP-1](https://www.mdpi.com/jcm/jcm-15-02909/article_deploy/html/images/jcm-15-02909-g002.png)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The Therapeutic Potential of GLP-1](https://media.licdn.com/dms/image/v2/D4E22AQEbmgsJxWPEcw/feedshare-shrink_800/B4EZyvpr99JIAg-/0/1772473467033?e=2147483647&v=beta&t=98-9e5B_TBWc0rbuGWElTJi-ipvPZcMSLDPm9coMUXM)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The Therapeutic Potential of GLP-1](https://onlinelibrary.wiley.com/cms/asset/5de523aa-5e6f-4998-8593-bac0b20c5b49/ijd70346-toc-0001-m.png)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The Therapeutic Potential of GLP-1](https://nextstepsinderm.com/wp-content/uploads/2025/12/JDD-Buzz_GLP-1.png)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The Therapeutic Potential of GLP-1](https://m3.healio.com/~/media/slack-news/dermatology/misc/infographics/2025/08_august/derm0725snchez-feliciano_ig1.jpg)
